The Vanguard Group 13D and 13G filings for Acceleron Pharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-10 10:30 am Purchase |
2020-12-31 | 13G | Acceleron Pharma Inc. XLRN |
The Vanguard Group | 5,028,578 8.350% |
863,431 (+20.73%) |
Filing |